Down-regulation of oncogenic miR-20a-5p and further regulating several important cancer genes (such as PTEN and BCL2) may provide a potential MOA for therapeutic effect of metformin in breast cencer (Figure 6B). The gene discussed is PTEN; the disease is cancer.